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Introduction
Observational studies are widely used to estimate treatment effectiveness; here the major concern is confounding (Moodie and Stephens, 2010) . Regression is often used to adjust for potential confounders, but if the distribution of baseline covariates does not overlap between the treatment groups, estimates may be highly sensitive to model specification (Rubin, 1997) . To reduce reliance on parametric assumptions, propensity score (Pscore) methods, including stratification, matching, regression adjustment and inverse probability of treatment weighting (IPTW), are widely used to estimate treatment effects (Austin, Austin and Laupacis, 2011) . Of these approaches, matching and IPTW can perform relatively well (Austin, 2009a) , and IPTW has been extended to allow for time-varying exposures and confounders . The Pscore specification must be considered by examining covariate balance after matching or weighting, and if the resultant balance is poor, the Pscore re-estimated. However, studies rarely follow this careful process, they often fail to assess covariate balance and may report biased estimates of treatment effectiveness based on misspecified Pscores (Austin, 2008a) .
Policy-makers require unbiased estimates of the average treatment effect (ATE), not just for an overall population but also for particular subgroups (Hasford et al., 2010) . For studies that aim to report treatment effects for each subgroup, correct Pscore specification is particularly challenging (Lefebvre and Gustafson, 2010) . A major concern is that each subgroup may have a different treatment assignment mechanism. Reliable inference then requires that the Pscore balances baseline characteristics across treatment groups within each subgroup. A Pscore approach has to then recognize the differential treatment assignment mechanism, for example by estimating separate Pscore models for each subgroup. If the Pscore is misspecified, because for example the same Pscore is used for each subgroup, then the treatment groups will be imbalanced. Hence IPTW or Pscore matching may provide incorrect inferences (Drake, 1993) .
Instead of relying on correct Pscore specification, covariate balance can be achieved with multivariate matching methods that attempt to directly balance individual characteristics, for example within each subgroup of interest. Genetic matching (GenMatch) combines Pscore matching with multivariate matching on the individual covariates, using an automated search algorithm to optimize covariate balance (Diamond and Sekhon, 2012; Sekhon, 2011) . GenMatch can reduce bias and mean squared error (MSE) compared to Pscore matching (Diamond and Sekhon, 2012; Sekhon, 2011) , and has been applied across a diverse range of settings (Gilligan and Woo et al., 2008) . Alternative automated approaches include using targeted maximum-likelihood estimation (e.g., van der Laan and Gruber, 2010; van der Laan, 2010a; van der Laan, 2010b). However, none of these papers compares GenMatch to IPTW, or reports treatment effectiveness for subgroups.
This paper aims to compare GenMatch to common ways of implementing Pscore matching and IPTW for tackling confounding, when reporting treatment effectiveness by subgroup. The methods are considered in a motivating example and a simulation study. The motivating example assesses the effectiveness of a controversial pharmaceutical intervention, Drotrecogin alfa activated (DrotAA) for severe sepsis, the most common cause of death in adult intensive care units (ICUs) (Rowan et al., 2008) . The Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial reported that DrotAA reduced overall 28-day mortality versus placebo (Bernard et al., 2001 ), but posthoc subgroup analysis suggested benefit solely for high-risk patients. These findings generated the hypothesis that the effectiveness of DrotAA may differ according to baseline severity. We compare alternative Pscore approaches in re-analyzing a previous observational study estimating the effectiveness of DrotAA (Rowan et al., 2008) . Each approach uses the previously published Pscore, which after matching, gave reasonable levels of covariate balance across the treatment groups (Rowan et al. 2008) according to conventional standards (Austin 2008a) . Unlike the previous study we recognize the differential treatment allocation by subgroup. We then conduct a simulation study that extends the motivating example, and examines the relative bias and precision following each Pscore approach, when the subgroup-specific treatment allocation is recognized, and then ignored. We also consider settings with baseline covariates that have poor overlap between the treatment groups, and according to different sample sizes.
Methods

Statistical methods
The methods considered all assume that confounding can be removed by balancing observed baseline covariates, and require choices to be made in advance, about which variables are potential confounders. Variables should be chosen for inclusion in the Pscore or matching algorithm, so as to balance potential confounders. The choice should not be based on statistical tests for baseline differences (Rubin, 2008) , but can draw on theory, published literature, expert opinion or causal diagrams (Pearl, 1995) .
For each statistical method we estimate ATEs. This estimand can be obtained for matching methods by matching both a control observation to each patient in the treatment group, and a treated observation to each observation in the control group (Abadie et al., 2001) , and this is the standard estimand for IPTW. The ATEs were reported for the same populations of interest, represented by the distribution of characteristics across both treatment groups in the unmatched data (Kurth et al., 2006) . For the matching approaches treated and control individuals were matched to their nearest neighbor in the comparison group, one-to-one, with replacement (Abadie and Imbens, 2009).
We report the treatment effects with a common measure, the marginal odds ratio (OR). Marginal effects have high policy relevance as they apply to the population or subpopulation of interest, whereas conditional effects refer to the individual. Except under certain restrictive settings (Greenland et al., 1999) marginal and conditional ORs differ, i.e. the OR is non-collapsible (Austin, 2007) . For IPTW, we weight observed outcomes for both treatment and control groups . For both matching approaches, we calculate ORs across all the matched pairs (Abadie et al., 2001) . Given concerns about the interpretability of ORs, in the case study we also report treatment effects as relative risks, using Poisson regression.
An important challenge for the statistical methods is that the treatment assignment mechanism may differ by subgroup. For example, the relative influence of factors explaining treatment assignment may differ for high risk versus low risk patients. Balancing baseline characteristics for overall samples of treated and control observations can leave potential confounders imbalanced at the subgroup-level. In this context the methods aim to achieve covariate balance at the subgroup level.
We used weighted standardized differences to assess covariate balance which is a recommended measure for comparing balance between IPTW and matching methods (Austin, 2009b) . Here the matching uses frequency weights, and IPTW the inverse of the Pscore, to weight the means and variances of the covariates (Austin, 2009b) . Some researchers suggest a standardized difference of 10% denotes meaningful imbalance (Austin, 2009b; Normand et al., 2001 ), others that balance should be maximized without limit (Sekhon, 2011; Imai et al., 2008 ).
Propensity score matching
Assuming no unobserved confounding and that the distributions of baseline covariates overlap between the treatment groups (Cole and Hernán, 2008) , matching on a correctly specified Pscore can balance observed covariates and reduce bias (Rosenbaum and Rubin, 1983) . To check the Pscore specification, covariate balance should be examined, and if balance is poor, the Pscore re-estimated (Rosenbaum and Rubin, 1984; Stuart, 2010) . If the Pscore model is misspecified, balance may not be achieved and the Pscore matching estimator is biased and inconsistent (Sekhon, 2011) . In particular, where ATEs are required for subgroups, and the treatment assignment mechanism differs by subgroup, matching on the Pscore estimated across the whole sample may not balance covariates in each subgroup of interest. Instead, for each subgroup separate Pscores can be estimated, and used to create subgroupspecific matched datasets. Rosenbaum and Rubin (1985) recommended combining matching on the Pscore with matching on individual covariates, using the Mahalanobis distance (MD). This approach improves balance if the covariates follow ellipsoidal distributions, such as the normal (Rubin, 1992) . However, in practice, this approach can lead to worse covariate balance, for example in the presence of binary variables, and in finite samples (Sekhon, 2011) .
Genetic matching -matching on the Pscore and individual covariates
GenMatch can combine matching on the Pscore and covariates, but rather than selecting matched pairs according to their closeness, this approach optimizes covariate balance between the matched treatment and control samples. GenMatch selects matched pairs using a generalized MD metric, which includes an additional vector of weights for each covariate included in the matching. The weights define different distance metrics, which differ in the relative importance given to matching on each covariate. An automated search algorithm selects those weights (Sekhon and Mebane, 1998; Mebane and Sekhon, 2011) , and hence the corresponding distance metric, that gives the best covariate balance in the matched samples. The choice of balance statistic has to be made a priori from recommended traditional measures, such as standardized mean differences, or more general measures such as Kolmogorov-Smirnov (KS) tests and empirical quantile plots (Austin, 2009b) . Balance can be optimized separately for the subgroups of interest, and treatment effects can be reported using separate matched datasets for each subgroup.
A general practical concern is that if a covariate chosen for the Pscore or GenMatch algorithm is not associated with outcome, then conditioning on this covariate will increase variance without reducing bias in the estimated treatment effect Brookhart et al., 2006; Schisterman et al., 2007) . If the GenMatch algorithm is required to balance unnecessary covariates (Schisterman et al., 2007) , this increases the dimensionality of the matching problem, which with a small sample size can increase the bias inherent in multivariate matching estimators (Abadie and Imbens, 2006) . More details on GenMatch are given in Appendix A. 
, whereπ i is the estimated Pscore for the i-th individual and T i is the treatment indicator. Individuals with a high predicted probability of the observed treatment receive a relatively low weight. When there is good overlap and the Pscore model is correctly specified, the IPTW estimator can provide unbiased and relatively efficient estimates of the ATE (Hirano et al., 2003) . However, even with good overlap, if the Pscore is misspecified, baseline covariates can be imbalanced, which can lead to bias and inefficiency (Pearl, 1995) . With poor overlap, the weights can be extreme which can lead to increased bias and variance (Pearl, 1995; Rosenbaum and Rubin 1983 ). Here, a recommended strategy is to truncate the weights (Cole and Hernán, 2008) . When there are different treatment assignment mechanisms for each subgroup, the weights can be taken from separate Pscores estimated for each subgroup.
Description of motivating example
A prospective cohort study previously matched patients who received DrotAA to controls, and reported that DrotAA was effective for high-risk (three to five organ failures at baseline), but not for low-risk patients (two organ failures) (Rowan et al., 2008) . However, this study did not consider whether potential confounders were balanced for each subgroup. Our reanalysis included in the Pscore the same baseline covariates, reported in Table 1 , as the original study (sample size n = 2, 726). To address confounding we extended the previous study and recognized that treatment allocation may differ by subgroup.
The Pscore methods initially used the original Pscore model, common across both patient subgroups (overall Pscore), and the GenMatch algorithm was required to improve covariate balance across the whole sample (overall GenMatch algorithm). The analyses were repeated but with separate Pscore models (subgroupspecific Pscore) and GenMatch algorithms (subgroup-specific GenMatch algorithm) for each subgroup defined a priori according to whether patients had two, or three to five organ failures (see Appendix B). Here, the matching methods created separate matched datasets for each subgroup.
For each method covariate balance was reported for those baseline factors which a priori were judged potential confounders. This list of variables for assessing balance differed from the set of variables in the Pscore and matching algorithm (see Table 1 ). Expert opinion was used to designate which of these variables were high, or low priority variables to balance (Sadique et al., 2011) . The most important confounders were anticipated to be age, the proportion ventilated at ICU admission (% Ventilated), the acute physiology score (IMscore), and the baseline probability of death, calculated as a function of 20 underlying physiological variables (IMprob). To balance these confounders, it was judged necessary to include in the Pscore, and matching algorithm each of the baseline covariates listed above, but not all these variables were designated potential confounders. Some of the covariates in the Pscore and matching algorithm were not regarded as important to balance themselves, but were included to help balance the major confounders (Sadique et al., 2011) . Of the variables designated as being of some importance, the GenMatch algorithm was required to maximise balance on the high and then the low priority variables. For further details on this approach to prioritising the covariates to balance see Ramsahai et al. (2011) .
To address imbalances beyond differences in means, matching methods can also use non-parametric KS tests (Diamond and Sekhon, 2012; Stuart 2010). As a sensitivity analysis, the GenMatch algorithm was modified to optimize balance assessed by KS and t-tests.
Marginal ORs were estimated by logistic regression applied to each matched dataset, and for IPTW the logistic regression incorporated weights calculated from each Pscore (Sekhon, 2011; Stuart, 2010) . As well as reporting ORs, we also reported relative risks. A sensitivity analysis was performed for IPTW by truncating the weights. There were no missing data.
Motivating example results
Here we present balance for those baseline covariates that were anticipated to be the major confounders: age, IMprob, IMscore and % ventilated. The standardized differences before matching were large for both subgroups (Table 2) , and there was reasonable overlap (Appendix C, Figure 3 ).
Following Pscore matching and IPTW, some large standardized differences remained for either subgroup, whether using the overall Pscore or the subgroupspecific Pscore (Table 3) . GenMatch reported better balance than the other methods when required to balance across the overall sample for one subgroup (3 to 5 organ failures), but for the other subgroup (2 organ failures) none of the methods was dominant in terms of covariate balance. Balance improved further when the algorithm balanced at the subgroup level. When subgroup-specific GenMatch algorithms were applied, GenMatch achieved better balance on the high priority variables than Pscore matching and IPTW and similar balance on the low priority variables (see Tables 8 and 9 , Appendix C). In the sensitivity analysis when KS statistics were included in the GenMatch optimization, GenMatch again reported improved balance for high priority variables and similar balance for low priority variables compared to the other approaches (see Appendix C, Tables 10, 11 and  12) . When the IPTW weights were truncated above the first and 99th percentiles, covariate balance worsened (see Appendix C, Table 13 ). a Note absolute standardized differences are reported as percentages. Table 4 reports marginal ORs for the effect of DrotAA versus control on hospital mortality. The corresponding relative risks are reported in Appendix C (Table 14) . The effectiveness of DrotAA differed by subgroup; the CIs for the treatment by subgroup interactions excluded zero (see Table 15 , Appendix C).
For the two organ failures subgroup, the point estimates all exceeded 1, but for IPTW the CIs were wide especially after weighting with the overall Pscore (Table 4) . GenMatch reported similar ORs whether the algorithm was required to match across the overall sample or for each subgroup. When GenMatch was required to optimize balance according to KS and t-tests, the estimated treatment effects were similar to the base case. 
Simulation description
We conducted Monte Carlo simulations to examine the relative performance of each method for estimating treatment effects by subgroup. The three scenarios considered were grounded in the motivating example, and prior concerns about each method. The first scenario misspecified the Pscore and the GenMatch algorithm by ignoring the subgroup specific treatment allocation, as in the motivating example. The second scenario considered poor overlap (see Figure 4 , Appendix C), and the omission of a non-linear term from the Pscore models and GenMatch algorithms. The last scenario included a covariate not associated with outcome in the Pscore models and GenMatch algorithms , and considered smaller sample sizes (n = 1, 000; n = 100) (Brookhart et al., 2006; Schisterman et al., 2007) .
Data generating process
We used a similar data generating process (DGP) to previous studies (Austin, 2009a; Austin 2007 ). For each subject, two continuous confounders X 1 and X 2 , were generated from a bivariate normal distribution. A third confounder, X 3 , defining the patient subgroup, was a binary variable generated from a Bernoulli distribution (see Appendix B). Treatment status, T and a binary outcome variable, Y were randomly generated from Bernoulli distributions with parameters π and p, determined by a different logistic model for each pair of scenarios (see below).
Scenario 1: subgroup-specific Pscore and GenMatch algorithm (1a) versus overall Pscore and GenMatch algorithm (1b)
For each subject, the logit of the Pscore, π, was determined by:
, and the logit of the parameter for the outcome model, p, by:
The interaction terms allowed the confounders to have a differential effect on treatment assignment according to subgroup (Pscore model), and allowed treatment effects to differ by subgroup (outcome model).
In the first scenario (1a), correctly specified subgroup-specific Pscores were used for matching and IPTW weights. Similarly, GenMatch was required to match and balance on X 1 , X 2 and the estimated linear predictor of π, separately for each subgroup. In scenario 1b, the Pscore and the GenMatch algorithm were both misspecified; the Pscore was estimated across both subgroups; GenMatch was required to match and balance on X 1 , X 2 and X 3 across the whole sample, and the overall linear predictor of π. In these scenarios there was good overlap in the distribution of the covariates and the Pscore between the treatment groups. All methods correctly attempted to maximize balance at the subgroup level, but this scenario considered poor overlap and misspecification of the treatment allocation mechanism by exclusion of a nonlinear term. The logit of the Pscore was given by: logit(π) = ln(0.1) − 0.4X 1 + 0.8X 2 + 1.2X 3 − 0.2X 2 1 X 3 , and the logit of the parameter for the binary outcome model was: logit(p) = −14 + 0.1T + 3X 1 + 0.5X 2 − 0.2X 3 + X 3 T . The means and standard deviations of the confounders X 1 , and X 2 were chosen to ensure poor overlap in the distribution of the Pscore and the key confounder X 1 , especially for the subgroup X 3 = 1 (for a comparison of overlap between Scenario 1 and 2, see Appendix C, Figure 4 ).
In scenario 2a we assumed a correctly specified Pscore, and GenMatch was asked to maximize balance on each confounder, including the nonlinear term X 2 1 . In scenario 2b, the treatment allocation models were misspecified for the X 3 = 1 subgroup by excluding X 2 1 .
Scenario 3: recommended exclusion of a covariate not associated with outcome (3a) versus inclusion of a covariate not associated with outcome (3b)
This scenario assumed good overlap, but the Pscore included a continuous normal covariate, X 4 , not associated with the outcome:
The outcome model was as in scenario 1.
In scenario 3a, X 4 was excluded from the estimated Pscore, and from the terms GenMatch was asked to balance. In scenario 3b, X 4 was included in the estimated Pscores and GenMatch algorithms.
We report marginal ORs as in the empirical example. Here the true marginal ORs were obtained by a Monte Carlo simulation with 10,000 samples of size 10, 000 (Austin, 2007) . In scenarios 1 and 3, these ORs were 1.105 (X 3 = 0) and 1.052 (X 3 = 1), and for scenario 2 they were 1.035, and 1.496. Recall that, owing to the non-collapsibility of the OR, the marginal ORs do not coincide with the conditional ORs (Austin, 2007) . Each scenario was run with 1,000 replications, each with a sample size of 2, 000. Scenario 3 was also run with smaller sample sizes (n = 1, 000; 100). For all scenarios we calculated the bias and root mean squared error (RMSE) of the estimated treatment effects. For sample R code for the simulation see Appendix B. Table 5 reports the weighted standardized differences for scenarios 1 and 2. With good overlap and correctly specified methods (scenario 1a), the standardized differences were small. When the Pscore model was misspecified by fitting an overall Pscore, and GenMatch failed to match and balance at the subgroup level (scenario 1b), both Pscore methods had high standardized differences compared to GenMatch. Under scenario 2, with weak overlap for the X 3 = 1 subgroup (Figure 4 , Appendix C), all methods reported worse covariate balance. The deterioration in balance was least for GenMatch and most for IPTW, here even with a correctly specified Pscore (scenario 2a) the nonlinear term, X 2 1 was highly imbalanced (standardized difference of 24). Under scenario 2b, the Pscore for the X 3 = 1 subgroup excluded the nonlinear term X 2 1 ; balance on this term deteriorated for each method, but remained worst for IPTW (standardized differences: 25, IPTW; 21, Pscore matching and 14 GenMatch). The left (right) panels of Figure 1 report bias and variation when the Pscores and the GenMatch algorithms are correctly (incorrectly) specified by recognizing (ignoring) the subgroup-specific treatment allocation (scenario 1). With correct specification, all methods reported treatment effects centered on their true values. Under misspecification, the estimated ORs were biased and more variable for Pscore matching and IPTW; for the X 3 = 1 subgroup, the relative biases were 13% (Pscore matching), 14% (IPTW) and 1% (GenMatch). The corresponding RMSEs were 0.20 (Pscore methods), and 0.08 (GenMatch). Figure 2 reports bias and variation for scenario 2, where overlap is poor. Under correct specification, Pscore matching and GenMatch reported moderate bias (8% and 3% for X 3 = 1). For IPTW, where covariate balance was poor for the X 2 1 term, bias was higher (15%, for X 3 = 1). The corresponding RMSE for IPTW was six times that for GenMatch. With misspecification, the biases were higher for each method (32% for IPTW, 21% for Pscore matching and 5% for GenMatch). To examine the IPTW weights scenario 2a was repeated with the same DGP but for a single dataset of 1, 000, 000 (Appendix C, Figure 5 ). For subgroup X 3 = 1, the weights for the treatment group are extreme which may explain the excessive bias and variance. When the IPTW weights were progressively truncated, the standardized differences increased (Appendix C, Table 16 ), and the IPTW estimator became less variable, but more biased (Appendix C, Figure 6 ). Table 6 reports the weighted standardized differences for scenario 3. With sample sizes of 2, 000 or 1, 000, the standardized differences for the true confounders (X 1 and X 2 ) remained small even if the methods were required to balance the covariate not associated with outcome (X 4 ). When the sample size was reduced to 100, balance on the confounders deteriorated especially following Pscore matching. a Across the replications the average number of treated versus controls was 69% treated, 31% controls (n = 2, 000), 66% treated, 34% controls (n = 1, 000), 68% treated, 32% controls (n = 100). b Weighted standardized differences are means across the 1, 000 simulations, and are reported as percentages. Table 7 reports bias and RMSE for scenario 3. With sample sizes of 2, 000 or 1, 000, all methods reported estimates that were relatively unbiased and statistically efficient. With a small sample size (n = 100), IPTW provided the least biased, most efficient estimates, but all methods performed poorly.
Simulation study results
Discussion
This paper compares GenMatch with common implementations of Pscore matching and IPTW. GenMatch is an approach that combines matching on the Pscore and the individual covariates. The study considers settings where both treatment effectiveness and the treatment assignment mechanism differ by subgroup, and the major concern is balancing time-constant covariates. The case study exemplifies a general methodological challenge, that of reporting unbiased estimates when treatment effectiveness is anticipated to differ by patient subgroup (Hasford et al., 2010; Lefebvre and Gustafson, 2010). The motivating example is in critical care, where risk adjustment is relatively advanced, and the assumption of no unmeasured confounding may be judged reasonable (Rowan et al., 2008) . Here it was anticipated that because receipt of DrotAA could differ by subgroup, a 'subgroup specific Pscore' would help balance covariates in each subgroup. However, achieving covariate balance with a Pscore is a challenging process (Austin, 2008) , and in this case study neither of the previously recommended Pscore methods (Austin, 2009a ) is able to balance covariates within the subgroups. By contrast the approach that combines matching on the Pscore and the individual covariates, does balance potential confounders in both subgroups. This case study highlights the importance of adopting an approach that achieves balance for subgroups, to enable policy makers to identify patients who would benefit most from treatment.
The simulation study finds that if, as in the motivating example, the estimated Pscore ignores a differential treatment allocation by subgroup, estimates can be biased and inefficient. GenMatch is relatively robust to this misspecification, because it aims to directly balance potential confounders using an automated search algorithm, rather than a fixed parametric model. This paper extends previous work that reports lower MSE for GenMatch compared to Pscore matching alone, or combined with MD matching (Diamond and Sekhon, 2012; Sekhon and Grieve, 2011; Kang and Schafer, 2007) . This is the first study to compare these three methods, and does so in an important context for policy makers -that of subgroup analysis.
IPTW is a common method for estimating treatment effectiveness with observational data. Unlike matching, IPTW extends to handling time-varying covariates , and can minimize MSE if the Pscore is correctly specified (Stuart, 2010) , but this changes the population of interest; a strength of this study is that it compares the methods in the same population. Our simulation highlights that with a small sample size, matching can lead to biased and statistically inefficient estimates relative to IPTW (Abadie and Imbens, 2006) . Multivariate matching methods such as GenMatch, that focus on balancing the individual covariates, may be particularly prone to bias and imprecision when the sample size is small (Abadie and Imbens, 2006) . This study has several limitations. Each approach assumes no unmeasured confounders, an untestable assumption which in many cases is implausible. Each method requires the analyst to choose the covariates, but also the statistics for balance assessment (Brookhart et al., 2006) . In the main analysis we followed recommendations and used weighted standardized mean differences (Austin, 2009b) , but more general balance statistics such as non-parametric Kolmogorov-Smirnoff tests warrant consideration and as the sensitivity analysis in the case study shows, can be considered by GenMatch (see also Diamond and Sekhon, 2012 ).
Conclusion
When the estimated Pscore is misspecified, an automated approach that combines matching on the Pscore and individual covariates can report less biased estimates of treatment effectiveness for patient subgroups than common ways of implementing Pscore matching or IPTW. The combined matching approach performs less well with small sample sizes. These findings apply to settings where treatment and potential confounders are time-constant.
Appendix A Genetic matching
Genetic matching (GenMatch) automates the process of maximizing balance on observed covariates in the matched sample by using an evolutionary search algorithm to determine the weight each individual covariate is given. As with any matching method, GenMatch requires choices to be made a priori about which covariates to include in the matching and assessment of balance, and which balance statistic to use. The key innovations of GenMatch are the generalised distance metric, and the use of an iterative search algorithm to maximize covariate balance. Diamond and Sekhon (2012) and Sekhon (2011) provided full details of the method and its properties in a general context, so here we summarize the key aspects.
Selection of covariates for matching algorithm
Before matching, it is necessary to choose which potential confounders to condition on. The researcher should follow general guidance and only consider those covariates anticipated to influence the outcome (Brookhart, 2006 ). This selection process should also consider interaction effects as well as main effects and nonlinear terms. The choice can be informed by previous empirical analyses, expert opinion, and causal diagrams (Rubin, 2008; Pearl, 1995) . The GenMatch algorithm will only use those matching variables that are pre-specified. As with any other matching method the choice of variables for balance assessment should include those anticipated to be of high prognostic importance whether or not they are included in the matching. For example, a summary prognostic measure may be excluded from the matching because it is highly correlated with the underlying covariates, and better overall balance may be achieved by just matching on the covariates. GenMatch can also be tailored to prioritise achieving covariate balance on particular covariates designated as high priority, for further details see Ramsahai et al. (2011) .
Covariate balance statistics
A recommended statistic for checking covariate balance is the weighted standardized mean difference:
where for continuous covariatesx and s 2 denote the covariate's weighted means and variances. This balance statistic allows matching methods to be compared to IPTW, by using the appropriate weights, i.e. the frequency weights in matched datasets, and the IPTW weights calculated from the Pscore. This measure can be adapted for binary variables (Austin, 2009b) . In some circumstances, the weighted standardized mean differences are an insufficient measure of balance as they are insensitive to imbalances in aspects of the covariate distribution beyond the mean (e.g., variance, maximum, skew, kurtosis). To address imbalances beyond differences in means for linear terms, matching methods can consider standardized differences for higher order terms, but also alternative balance statistics such as Kolmogorov-Smirnov (KS) tests and empirical quantile-quantile plots (Austin, 2009b) . A potential advantage of GenMatch is that it can maximise balance according to whatever balance statistic the user specifies including the more general measures listed above.
Distance metric
The Mahalanobis distance (MD) between any two observations (one from treatment and the other from control) is
where S is the sample covariance matrix of X and X T is the transpose of the matrix X. Using this metric, distance between individual covariates is collapsed into a single scalar. The Pscore can be combined with MD by, for example, including the Pscore as a variable in the X matrix in (1) .
GenMatch generalizes the MD by including an additional weight matrix W:
where W is a k × k positive definite weight matrix with k being the number of matching covariates , and S −1/2 is the Cholesky decomposition of S. GenMatch essentially matches by minimizing the generalized version of MD given in (2) . W is chosen to be the weight matrix that minimizes covariate imbalance according to the balance statistics the user chooses (e.g., standardized difference, KS statistics). The GenMatch algorithm uses the distance measure, GMD (equation 2) in which (by default) all elements of W are zero except down the main diagonal. The main diagonal is the vector of weights chosen by the algorithm. If each of the weights for the covariates are set equal to one and the weight for the Pscore is zero, GMD is the same as MD. That is, GenMatch will converge to the MD if that proves to be the optimal distance measure. If the Pscore contains all the information required to maximize covariate balance, the algorithm will converge to the corresponding distance metric, that is, the Pscore will be given full weight, and the other elements in W will be given zero weight. Hence, both Pscore and MD matching can be considered as limiting cases of GenMatch. The inclusion of individual covariates in the X matrix, rather than relying solely on the specification of the Pscore, helps ensure covariate balance when the Pscore is misspecified. In this sense, GenMatch is robust to misspecifications in the Pscore.
The iterative search algorithm
Here we provide an overview of the optimization algorithm. Further details are available in Sekhon and Mebane (1998) and Mebane and Sekhon (2011) .
The aim of the GenMatch algorithm is to find the optimal weights, W, that is the weights which produce the matched sample with the best balance. GenMatch uses a genetic search algorithm to search the weight matrices W, where each possible vector of weights corresponds to a different distance metric as defined in equation (2) . The algorithm proposes batches of weights, W and moves towards the batch which contains the optimal weights. Each batch is a generation and is used iteratively to produce a subsequent generation with better candidate W. The size of each generation is the population size (e.g., 1,000) and is constant for all generations. For each generation the sample is matched according to each metric, corresponding to each W, to produce as many matched samples as the population size. Balance is evaluated for each matched sample and the algorithm identifies the weights corresponding to the best balance. The generation of candidate Ws evolves towards those containing, on average, better W and asymptotically converges to contain the optimal W: the one which maximizes balance.
The X matrix includes all variables which are matched on and is used to define the GMD between units. The balance matrix consists of columns of data for each variable used to measure balance, and by default, the balance matrix is identical to the X matrix. Optimization can be stopped if there is no significant 22 improvement in the minimum loss over a specified number of generations or it can be stopped after a fixed number of generations (e.g., 200). Diamond and Sekhon (2008) conducted an extensive simulation study to compare the performance of GenMatch to other matching methods (Pscore matching, MD matching, Pscore and MD matching combined). The results showed that GenMatch produced better covariate balance in each of the settings considered. Where the Pscore was correctly specified and the covariates were multivariate normal, GenMatch dominated the other multivariate matching methods in terms of bias and MSE, and reported lower MSE than Pscore matching. When the Pscore was misspecified, GenMatch reported lower bias and MSE than the other estimators.
Previous simulation evidence
Sekhon and Grieve (2011) compared GenMatch to Pscore matching in a challenging setting where some covariates were discrete, and others continuous but with highly skewed distributions. The simulation reported that GenMatch achieved better covariate balance, lower bias and MSE, compared with Pscore matching.
Diamond and Sekhon (2012) compared the performance of GenMatch to Pscore matching, where the Pscore was estimated by a linear logistic regression model, random forests and boosted Classification and Regression Trees. The simulations considered scenarios that differed in the degree of linearity and additivity in the true Pscore model, that is the extent to which the Pscore model included quadratic and interaction terms. GenMatch reported the smallest MSE and bias, apart from one scenario where matching on the correctly specified Pscore model gave least bias.
Implementation
Various matching options can be implemented in the GenMatch software (Sekhon, 2011) . For example, matching can be performed with or without replacement, with calipers, 1:1 or 1:n, with or without ties. Software and further details can be found at the following web page: http://sekhon.berkeley.edu/matching/.
pmodel.X3<-glm(tx~X1+X2+X3,family=binomial,data=dataset.X3) pmodel.noX3<-glm(tx~X1+X2+X3,family=binomial,data=dataset.noX3) and the linear predictors, pscore.lin.X3 and pscore.lin.noX3, and Pscore weights pscorwght.X3 and pscorwght.noX3, calculated. Pscore matching was performed separately for the two subgroups using the commands: Table 3 in the main document. The results were obtained by fitting a logistic model with treatment, subgroup, and treatment by subgroup interaction terms as independent covariates. Results are reported for i) an overall Pscore or GenMatch algorithm and ii) a subgroup-specific Pscore or GenMatch algorithm. . Distribution of weights for IPTW for treatment and control observations in the X 3 = 1 subgroup, generated for a typical sample (n = 1, 000, 000). 
